About 60 patient and consumer advocates told House and Senate leadership to reject proposals to cut back the number of patients and safety net providers that are eligible for the 340B drug discount program, though the groups say they support transparency in the program. The move comes as lawmakers in both chambers of Congress and the president call for changes to the program. “We are troubled by assertions that the program has grown too large, suggestions that safety net providers...